p53 overexpression as a marker of poor prognosis in mantle cell lymphomas with t(11;14)(q13;q32).

Abstract:

:The t(11;14)(q13;q32) translocation, which juxtaposes the BCL1 oncogene with the Ig heavy chain locus, has been associated with an uncommon subtype of non-Hodgkin's lymphoma (NHL) termed mantle cell lymphoma (MCL). To date, no molecular marker that serves as an indicator of tumor progression or clinical prognosis has been described for NHLs with this translocation. We examined a panel of NHLs with t(11;14) for overexpression of p53 and correlated the results with single-strand conformation polymorphism (SSCP) analysis, karyotypic features, and clinical course. NHLs with t(11;14) were identified from 30 patients. The diagnosis was MCL for 23 of 30, small lymphocytic lymphoma for 4 of 30, and diffuse large-cell lymphoma for 3 of 30 cases. The results of immunohistochemistry analysis using a monoclonal anti-p53 antibody on paraffin-embedded specimens were compared with the SSCP data, the tumor karyotypes, and clinical course of each patient. DNA sequencing of exons was performed on cases that showed conformational changes by SSCP analysis. NHLs from 5 of 23 patients with MCL were positive for p53 overexpression. Deletions of chromosome 17p were identified in 2 of 30 cases, both of which were MCLs showing p53 overexpression. Two of the five MCLs with p53 overexpression showed evidence for TP53 mutations. None of the 18 MCLs negative for p53 overexpression showed conformational changes by SSCP. For these 18 patients with MCLs that did not overexpress p53, the median survival was 63 months, compared with 12 months for the 5 patients with MCLs positive for p53 overexpression (P < .001). These results suggest that p53 overexpression in MCL with t(11;14)(q13;q32) may serve as a marker of poor prognosis.

journal_name

Blood

journal_title

Blood

authors

Louie DC,Offit K,Jaslow R,Parsa NZ,Murty VV,Schluger A,Chaganti RS

subject

Has Abstract

pub_date

1995-10-15 00:00:00

pages

2892-9

issue

8

eissn

0006-4971

issn

1528-0020

journal_volume

86

pub_type

杂志文章

相关文献

BLOOD文献大全
  • IL10RA modulates crizotinib sensitivity in NPM1-ALK+ anaplastic large cell lymphoma.

    abstract::Anaplastic large cell lymphoma (ALCL) is a T-cell malignancy predominantly driven by a hyperactive anaplastic lymphoma kinase (ALK) fusion protein. ALK inhibitors, such as crizotinib, provide alternatives to standard chemotherapy with reduced toxicity and side effects. Children with lymphomas driven by nucleophosmin 1...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2019003793

    authors: Prokoph N,Probst NA,Lee LC,Monahan JM,Matthews JD,Liang HC,Bahnsen K,Montes-Mojarro IA,Karaca-Atabay E,Sharma GG,Malik V,Larose H,Forde SD,Ducray SP,Lobello C,Wang Q,Luan SL,Pospíšilová Š,Gambacorti-Passerini C,Burk

    更新日期:2020-10-01 00:00:00

  • Absence of immunogenicity of diaspirin cross-linked hemoglobin in humans.

    abstract::Diaspirin cross-linked hemoglobin (DCLHb) is an intramolecularly cross-linked hemoglobin-based oxygen carrier being developed as a therapy for acute blood loss. We report here the absence of immunogenicity of DCLHb in patients enrolled in phase II and III clinical trials of DCLHb. Two very sensitive immunoassays, an e...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Patel MJ,Webb EJ,Shelbourn TE,Mattia-Goldberg C,George AJ,Zhang F,Moore EG,Nelson DJ

    更新日期:1998-01-15 00:00:00

  • Inhibition of the intrinsic factor X activating complex by protein S: evidence for a specific binding of protein S to factor VIII.

    abstract::Protein S is a vitamin K-dependent nonenzymatic anticoagulant protein that acts as a cofactor to activated protein C. Recently it was shown that protein S inhibits the prothrombinase reaction independent of activated protein C. In this study, we show that protein S can also inhibit the intrinsic factor X activation vi...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Koppelman SJ,Hackeng TM,Sixma JJ,Bouma BN

    更新日期:1995-08-01 00:00:00

  • Expression of spliced oncogenic Ikaros isoforms in Philadelphia-positive acute lymphoblastic leukemia patients treated with tyrosine kinase inhibitors: implications for a new mechanism of resistance.

    abstract::Ikaros plays an important role in the control of differentiation and proliferation of all lymphoid lineages. The expression of short isoforms lacking DNA-binding motifs alters the differentiation capacities of hematopoietic progenitors, arresting lineage commitment. We sought to determine whether molecular abnormaliti...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-09-112631

    authors: Iacobucci I,Lonetti A,Messa F,Cilloni D,Arruga F,Ottaviani E,Paolini S,Papayannidis C,Piccaluga PP,Giannoulia P,Soverini S,Amabile M,Poerio A,Saglio G,Pane F,Berton G,Baruzzi A,Vitale A,Chiaretti S,Perini G,Foà R

    更新日期:2008-11-01 00:00:00

  • A randomized, placebo-controlled trial of recombinant human granulocyte colony-stimulating factor administration in newborn infants with presumed sepsis: significant induction of peripheral and bone marrow neutrophilia.

    abstract::Host defenses in the human neonate are limited by immaturity in phagocytic immunity. Such limitations seem to predispose infected newborns to neutropenia from an exhaustion of the neutrophil reserve. Among the critical defects thus far identified in neonatal phagocytic immunity is a specific reduction in the capacity ...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Gillan ER,Christensen RD,Suen Y,Ellis R,van de Ven C,Cairo MS

    更新日期:1994-09-01 00:00:00

  • Allogeneic peripheral blood progenitor cell transplantation in a murine model: evidence for an improved graft-versus-leukemia effect.

    abstract::Peripheral blood progenitor cells (PBPCs) are increasingly being used to replace bone marrow cells (BMCs) as a source of hematopoietic stem cells also in the field of allogeneic transplantation. Whereas it is well known that PBPC grafts and BM differ significantly in progenitor cell content and lymphocyte dose, the cl...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Glass B,Uharek L,Zeis M,Dreger P,Löffler H,Steinmann J,Schmitz N

    更新日期:1997-08-15 00:00:00

  • Hemophilia B Leyden: substitution of thymine for guanine at position -21 results in a disruption of a hepatocyte nuclear factor 4 binding site in the factor IX promoter.

    abstract::Hemophilia B Leyden is an X chromosome-linked bleeding disorder characterized by an altered developmental expression of blood coagulation factor IX. This form of hemophilia B has been found to be associated with a variety of single point mutations in the factor IX promoter region. We now describe a novel point mutatio...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Reijnen MJ,Peerlinck K,Maasdam D,Bertina RM,Reitsma PH

    更新日期:1993-07-01 00:00:00

  • Nonclonal hemopoietic progenitor cells detected in long-term marrow cultures from a Turner syndrome mosaic with chronic myeloid leukemia.

    abstract::We have investigated the clonality of Ph1-negative hemopoietic progenitor cells appearing in long-term marrow cultures established with cells from a mosaic Turner syndrome patient (46,XX/45,X) with Ph1-positive chronic myeloid leukemia (CML). The Ph1-positive clone had been shown previously to have arisen from a cell ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Dubé ID,Arlin ZA,Kalousek DK,Eaves CJ,Eaves AC

    更新日期:1984-12-01 00:00:00

  • An evolutionarily ancient mechanism for regulation of hemoglobin expression in vertebrate red cells.

    abstract::The oxygen transport function of hemoglobin (HB) is thought to have arisen ∼500 million years ago, roughly coinciding with the divergence between jawless (Agnatha) and jawed (Gnathostomata) vertebrates. Intriguingly, extant HBs of jawless and jawed vertebrates were shown to have evolved twice, and independently, from ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2020004826

    authors: Miyata M,Gillemans N,Hockman D,Demmers JAA,Cheng JF,Hou J,Salminen M,Fisher CA,Taylor S,Gibbons RJ,Ganis JJ,Zon LI,Grosveld F,Mulugeta E,Sauka-Spengler T,Higgs DR,Philipsen S

    更新日期:2020-07-16 00:00:00

  • Tissue factor pathway inhibitor dose-dependently inhibits coagulation activation without influencing the fibrinolytic and cytokine response during human endotoxemia.

    abstract::Inhibition of the tissue factor pathway has been shown to attenuate the activation of coagulation and to prevent death in a gram-negative bacteremia primate model of sepsis. It has been suggested that tissue factor influences inflammatory cascades other than the coagulation system. The authors sought to determine the ...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: de Jonge E,Dekkers PE,Creasey AA,Hack CE,Paulson SK,Karim A,Kesecioglu J,Levi M,van Deventer SJ,van Der Poll T

    更新日期:2000-02-15 00:00:00

  • Retinoic acid inhibits CD40 + interleukin-4-mediated IgE production in vitro.

    abstract::To elucidate the role of retinoic acid (RA) in anti-CD40 + interleukin-4 (IL-4)-mediated B-cell activation, the effect of 10(-12) to 10(-6) mol/L RA was studied in anti-CD40 (1 microgram/mL) + IL-4 (5 ng/mL)-mediated proliferation and Ig synthesis by human peripheral blood mononuclear cells (PBMC) and B cells in healt...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Worm M,Krah JM,Manz RA,Henz BM

    更新日期:1998-09-01 00:00:00

  • L-Leucine improves the anemia and developmental defects associated with Diamond-Blackfan anemia and del(5q) MDS by activating the mTOR pathway.

    abstract::Haploinsufficiency of ribosomal proteins (RPs) has been proposed to be the common basis for the anemia observed in Diamond-Blackfan anemia (DBA) and myelodysplastic syndrome with loss of chromosome 5q [del(5q) MDS]. We have modeled DBA and del(5q) MDS in zebrafish using antisense morpholinos to rps19 and rps14, respec...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-10-382986

    authors: Payne EM,Virgilio M,Narla A,Sun H,Levine M,Paw BH,Berliner N,Look AT,Ebert BL,Khanna-Gupta A

    更新日期:2012-09-13 00:00:00

  • The AKT kinase is activated in multiple myeloma tumor cells.

    abstract::Immunohistochemistry (IHC) was performed on archived bone marrow (BM) with a phosphospecific anti-AKT antibody. IHC on 26 BM biopsies from patients with multiple myeloma (MM) demonstrated phospho-AKT staining of malignant plasma cells in a cell membrane-specific pattern, whereas nonmalignant hematopoietic cells did no...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v98.9.2853

    authors: Hsu J,Shi Y,Krajewski S,Renner S,Fisher M,Reed JC,Franke TF,Lichtenstein A

    更新日期:2001-11-01 00:00:00

  • A risk-adapted, response-based approach using ABVE-PC for children and adolescents with intermediate- and high-risk Hodgkin lymphoma: the results of P9425.

    abstract::Current treatment strategies for Hodgkin lymphoma result in excellent survival but often confer significant long-term toxicity. We designed ABVE-PC (doxorubicin, bleomycin, vincristine, etoposide, prednisone, cyclophosphamide) to (1) enhance treatment efficacy by dose-dense drug delivery and (2) reduce risk of long-te...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1182/blood-2008-10-184143

    authors: Schwartz CL,Constine LS,Villaluna D,London WB,Hutchison RE,Sposto R,Lipshultz SE,Turner CS,deAlarcon PA,Chauvenet A

    更新日期:2009-09-03 00:00:00

  • Cytokine polymorphisms in the Th1/Th2 pathway and susceptibility to non-Hodgkin lymphoma.

    abstract::Studies have demonstrated that common polymorphisms in Th1 and Th2 cytokine genes can alter gene expression, modulate the balance between Th1/Th2 responsiveness, and influence susceptibility for autoimmune disorders, infectious diseases, and cancer. We analyzed one or more single nucleotide polymorphisms (SNPs) in 20 ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-10-4160

    authors: Lan Q,Zheng T,Rothman N,Zhang Y,Wang SS,Shen M,Berndt SI,Zahm SH,Holford TR,Leaderer B,Yeager M,Welch R,Boyle P,Zhang B,Zou K,Zhu Y,Chanock S

    更新日期:2006-05-15 00:00:00

  • Is 600 mg/m2 the appropriate dosage of busulfan in children undergoing bone marrow transplantation?

    abstract::Recent studies have reported that the pharmacokinetics of high-dose busulfan in bone marrow transplantation (BMT) are age-dependent: with the usual dosage of 16 mg/kg over 4 days, systemic exposure is two to four times lower in children than in adults. Data suggested that the dose of busulfan should rather be calculat...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Vassal G,Deroussent A,Challine D,Hartmann O,Koscielny S,Valteau-Couanet D,Lemerle J,Gouyette A

    更新日期:1992-05-01 00:00:00

  • Peptidoglycan from the gut microbiota governs the lifespan of circulating phagocytes at homeostasis.

    abstract::Maintenance of myeloid cell homeostasis requires continuous turnover of phagocytes from the bloodstream, yet whether environmental signals influence phagocyte longevity in the absence of inflammation remains unknown. Here, we show that the gut microbiota regulates the steady-state cellular lifespan of neutrophils and ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2015-10-675173

    authors: Hergott CB,Roche AM,Tamashiro E,Clarke TB,Bailey AG,Laughlin A,Bushman FD,Weiser JN

    更新日期:2016-05-19 00:00:00

  • Interleukin-24 inhibits the plasma cell differentiation program in human germinal center B cells.

    abstract::Complex molecular mechanisms control B-cell fate to become a memory or a plasma cell. Interleukin-24 (IL-24) is a class II family cytokine of poorly understood immune function that regulates the cell cycle. We previously observed that IL-24 is strongly expressed in leukemic memory-type B cells. Here we show that IL-24...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-05-220251

    authors: Maarof G,Bouchet-Delbos L,Gary-Gouy H,Durand-Gasselin I,Krzysiek R,Dalloul A

    更新日期:2010-03-04 00:00:00

  • Five years of experience with hydroxyurea in children and young adults with sickle cell disease.

    abstract::The short-term beneficial effect of hydroxyurea (HU) in sickle cell disease (SCD) has been proven by randomized studies in children and adults. The Belgian registry of HU-treated SCD patients was created to evaluate its long-term efficacy and toxicity. The median follow-up of the 93 patients registered is 3.5 years; c...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v97.11.3628

    authors: Ferster A,Tahriri P,Vermylen C,Sturbois G,Corazza F,Fondu P,Devalck C,Dresse MF,Feremans W,Hunninck K,Toppet M,Philippet P,Van Geet C,Sariban E

    更新日期:2001-06-01 00:00:00

  • Plasmodium vivax: restricted tropism and rapid remodeling of CD71-positive reticulocytes.

    abstract::Plasmodium vivax merozoites only invade reticulocytes, a minor though heterogeneous population of red blood cell precursors that can be graded by levels of transferrin receptor (CD71) expression. The development of a protocol that allows sorting reticulocytes into defined developmental stages and a robust ex vivo P vi...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2014-08-596015

    authors: Malleret B,Li A,Zhang R,Tan KS,Suwanarusk R,Claser C,Cho JS,Koh EG,Chu CS,Pukrittayakamee S,Ng ML,Ginhoux F,Ng LG,Lim CT,Nosten F,Snounou G,Rénia L,Russell B

    更新日期:2015-02-19 00:00:00

  • Intraarticular factor IX protein or gene replacement protects against development of hemophilic synovitis in the absence of circulating factor IX.

    abstract::Hemophilic bleeding into joints causes synovial and microvascular proliferation and inflammation (hemophilic synovitis) that contribute to end-stage joint degeneration (hemophilic arthropathy), the major morbidity of hemophilia. New therapies are needed for joint deterioration that progresses despite standard intraven...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-01-131417

    authors: Sun J,Hakobyan N,Valentino LA,Feldman BL,Samulski RJ,Monahan PE

    更新日期:2008-12-01 00:00:00

  • AML with 11q23/MLL abnormalities as defined by the WHO classification: incidence, partner chromosomes, FAB subtype, age distribution, and prognostic impact in an unselected series of 1897 cytogenetically analyzed AML cases.

    abstract::Acute myeloid leukemia (AML) cases with 11q23 abnormalities involving the MLL gene comprise one category of recurring genetic abnormalities in the WHO classification. In an unselected series of 1897 AML cases, 54 patients with an 11q23/MLL rearrangement were identified, resulting in an incidence of 2.8%. The incidence...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-02-0434

    authors: Schoch C,Schnittger S,Klaus M,Kern W,Hiddemann W,Haferlach T

    更新日期:2003-10-01 00:00:00

  • Stimulation of persisting colonies in agar cultures by sera from patients with CML and AML.

    abstract::Cord plasma contains colony-stimulating activity (CSA) which stimulates the in vitro clonal growth of neutrophils, eosinophils, macrophages, erythrocytes, and persisting mast cells in semisolid cultures. Analysis of day 35 colonies in agar cultures was found to be a suitable means of demonstrating this activity and di...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Brown RD,Yuen E,Kronenberg H,Rickard KA

    更新日期:1986-07-01 00:00:00

  • Targeting the Ras signaling pathway: a rational, mechanism-based treatment for hematologic malignancies?

    abstract::A series of alterations in the cellular genome affecting the expression or function of genes controlling cell growth and differentiation is considered to be the main cause of cancer. These mutational events include activation of oncogenes and inactivation of tumor suppressor genes. The elucidation of human cancer at t...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:

    authors: Reuter CW,Morgan MA,Bergmann L

    更新日期:2000-09-01 00:00:00

  • Mapping of distinct von Willebrand factor domains interacting with platelet GPIb and GPIIb/IIIa and with collagen using monoclonal antibodies.

    abstract::We have used monoclonal antibodies (M Abs) and proteolytic fragmentation to localize structurally the functional sites of human von Willebrand factor (vWF) responsible for interaction with membrane glycoproteins GPIb, GPIIb/IIIa, and with collagen. SpII (215 kd) and SpIII (320 kd), the S aureus V-8 protease homodimeri...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Girma JP,Kalafatis M,Piétu G,Lavergne JM,Chopek MW,Edgington TS,Meyer D

    更新日期:1986-05-01 00:00:00

  • Expression of fibrinogen receptors during activation and subsequent desensitization of human platelets by epinephrine.

    abstract::Epinephrine causes platelet aggregation and secretion by interacting with alpha 2-adrenergic receptors on the platelet surface. Platelet aggregation requires the binding of fibrinogen to a specific receptor on the membrane glycoprotein IIb-IIIa complex. Although the IIb-IIIa complex is identifiable on the surface of r...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Shattil SJ,Motulsky HJ,Insel PA,Flaherty L,Brass LF

    更新日期:1986-12-01 00:00:00

  • IL-7 and IL-15 instruct the generation of human memory stem T cells from naive precursors.

    abstract::Long-living memory stem T cells (T(SCM)) with the ability to self-renew and the plasticity to differentiate into potent effectors could be valuable weapons in adoptive T-cell therapy against cancer. Nonetheless, procedures to specifically target this T-cell population remain elusive. Here, we show that it is possible ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-05-431718

    authors: Cieri N,Camisa B,Cocchiarella F,Forcato M,Oliveira G,Provasi E,Bondanza A,Bordignon C,Peccatori J,Ciceri F,Lupo-Stanghellini MT,Mavilio F,Mondino A,Bicciato S,Recchia A,Bonini C

    更新日期:2013-01-24 00:00:00

  • Age-related defects in B lymphopoiesis underlie the myeloid dominance of adult leukemia.

    abstract::Reduced lymphopoiesis during aging contributes to declines in immunity, but little consideration has been given to its effect on the development of hematologic disease. This report demonstrates that age-related defects in lymphopoiesis underlie the myeloid dominance of adult leukemia. Using a murine model of chronic m...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-01-069401

    authors: Signer RA,Montecino-Rodriguez E,Witte ON,McLaughlin J,Dorshkind K

    更新日期:2007-09-15 00:00:00

  • Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells.

    abstract::The molecular mechanisms by which mesenchymal stem cells (MSCs) suppress T-cell proliferation are poorly understood, and whether a soluble factor plays a major role remains controversial. Here we demonstrate that the T-cell-receptor complex is not a target for the suppression, suggesting that downstream signals mediat...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-02-002246

    authors: Sato K,Ozaki K,Oh I,Meguro A,Hatanaka K,Nagai T,Muroi K,Ozawa K

    更新日期:2007-01-01 00:00:00

  • Low NAD(P)H:quinone oxidoreductase activity is associated with increased risk of leukemia with MLL translocations in infants and children.

    abstract::An inactivating polymorphism at position 609 in the NAD(P)H:quinone oxidoreductase 1 gene (NQO1 C609T) is associated with an increased risk of adult leukemia. A small British study suggested that NQO1 C609T was associated with an increased risk of infant leukemias with MLL translocations, especially infant acute lymph...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2001-12-0264

    authors: Smith MT,Wang Y,Skibola CF,Slater DJ,Lo Nigro L,Nowell PC,Lange BJ,Felix CA

    更新日期:2002-12-15 00:00:00